ロード中...
Incidence and risk of hepatic toxicities with PD-1 inhibitors in cancer patients: a meta-analysis
PURPOSE: Anti-programmed cell death receptor-1 (PD-1) antibodies have demonstrated antitumor activity in many cancer entities. Hepatic adverse events (AEs) are one of its major side effects, but the overall risks have not been systematically evaluated. Thus, we conducted this meta-analysis to invest...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5047728/ https://ncbi.nlm.nih.gov/pubmed/27729774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S115493 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|